Amarantus Bioscience Holdings Inc (AMBS)

[Solantey]

MANF could be $1,700,000,000 and fifteen years from reaching the market in some form as a useful drug.

About one in 5,000 drugs make it from pre-clinical tests to F.D.A. approval.

Unless the company finds a partner this is substantially overvalued currently.

http://www.pdpipeline.org/2011/Eithics/navagating/regulatory.htm

"Pigs get fat and hogs get slaughtered."

Volatility rules penny stocks.

Interesting weeks ahead.

"Buy on the rumor sell on the news."

p.s. This is overdue for a classic bear raid. I think it could retest the .065 level or lower.

GLTA/IMHO